Veeravagu A - Search Results

1

Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions.

Veeravagu A, Guzman R, Patil CG, Hou LC, Lee M, Steinberg GK. Veeravagu A, et al. Neurosurg Focus. 2008;24(2):E16. doi: 10.3171/FOC/2008/24/2/E16. Neurosurg Focus. 2008. PMID: 18275292 Review.

2

Recurrent glioblastoma multiforme: a review of natural history and management options.

Hou LC, Veeravagu A, Hsu AR, Tse VC. Hou LC, et al. Among authors: veeravagu a. Neurosurg Focus. 2006 Apr 15;20(4):E5. doi: 10.3171/foc.2006.20.4.2. Neurosurg Focus. 2006. PMID: 16709036 Review.

3

In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model.

Hsu AR, Hou LC, Veeravagu A, Greve JM, Vogel H, Tse V, Chen X. Hsu AR, et al. Among authors: veeravagu a. Mol Imaging Biol. 2006 Nov-Dec;8(6):315-23. doi: 10.1007/s11307-006-0059-y. Mol Imaging Biol. 2006. PMID: 17053862

4

Spinal gout in a renal transplant patient: a case report and literature review.

Hou LC, Hsu AR, Veeravagu A, Boakye M. Hou LC, et al. Among authors: veeravagu a. Surg Neurol. 2007 Jan;67(1):65-73; discussion 73. doi: 10.1016/j.surneu.2006.03.038. Epub 2006 Oct 6. Surg Neurol. 2007. PMID: 17210304 Review.

5

Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.

Hsu AR, Cai W, Veeravagu A, Mohamedali KA, Chen K, Kim S, Vogel H, Hou LC, Tse V, Rosenblum MG, Chen X. Hsu AR, et al. Among authors: veeravagu a. J Nucl Med. 2007 Mar;48(3):445-54. J Nucl Med. 2007. PMID: 17332623 Free article.

6

Molecular events of brain metastasis.

Santarelli JG, Sarkissian V, Hou LC, Veeravagu A, Tse V. Santarelli JG, et al. Among authors: veeravagu a. Neurosurg Focus. 2007 Mar 15;22(3):E1. doi: 10.3171/foc.2007.22.3.2. Neurosurg Focus. 2007. PMID: 17608351 Review.

7

CyberKnife radiosurgical rhizotomy for the treatment of atypical trigeminal nerve pain.

Patil CG, Veeravagu A, Bower RS, Li G, Chang SD, Lim M, Adler JR Jr. Patil CG, et al. Among authors: veeravagu a. Neurosurg Focus. 2007;23(6):E9. doi: 10.3171/FOC-07/12/E9. Neurosurg Focus. 2007. PMID: 18081486 Clinical Trial.

8

Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy.

Veeravagu A, Hsu AR, Cai W, Hou LC, Tse VC, Chen X. Veeravagu A, et al. Recent Pat Anticancer Drug Discov. 2007 Jan;2(1):59-71. doi: 10.2174/157489207779561426. Recent Pat Anticancer Drug Discov. 2007. PMID: 18221053 Review.

9

Integrin alpha v beta 3 antagonists for anti-angiogenic cancer treatment.

Hsu AR, Veeravagu A, Cai W, Hou LC, Tse V, Chen X. Hsu AR, et al. Among authors: veeravagu a. Recent Pat Anticancer Drug Discov. 2007 Jun;2(2):143-58. doi: 10.2174/157489207780832469. Recent Pat Anticancer Drug Discov. 2007. PMID: 18221059 Review.

10

The cancer stem cell-vascular niche complex in brain tumor formation.

Veeravagu A, Bababeygy SR, Kalani MY, Hou LC, Tse V. Veeravagu A, et al. Stem Cells Dev. 2008 Oct;17(5):859-67. doi: 10.1089/scd.2008.0047. Stem Cells Dev. 2008. PMID: 18429673 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters